Guru Fundamental Report for JNJ

Validea's guru fundamental report indicates that Johnson & Johnson (JNJ) receives a rating of 87% based on their Multi-Factor Investor model, which is based on the investment strategy of Pim van Vliet, who focuses on low volatility stocks with strong momentum and high net payout yields; the report notes JNJ passes the market cap and standard deviation tests, but is neutral on momentum and net payout yield, and fails the final rank within this strategy.

Analysis

Johnson & Johnson (JNJ), a large-cap growth stock in the Biotechnology & Drugs industry, has received an 87% rating from Validea's Multi-Factor Investor model, based on Pim van Vliet's strategy emphasizing low volatility, strong momentum, and high net payout yields. This score, where 80% or above typically indicates strategic interest, reflects JNJ's underlying fundamentals and valuation. The analysis confirms JNJ passes the model's tests for market capitalization and standard deviation, aligning with the desired low volatility profile. However, JNJ is assessed as 'NEUTRAL' on both twelve-minus-one momentum and net payout yield, which are critical components of the van Vliet approach. Consequently, despite the high overall rating and a reported positive ticker sentiment of 0.75, the stock receives a 'FAIL' on the 'FINAL RANK' within the detailed strategy criteria, indicating it does not comprehensively meet all specific requirements of this particular conservative factor investing model.

Key Decisions for Investors

• Investors should interpret Validea's 87% rating for JNJ as indicative of fundamental strength and recognized low-volatility characteristics, but note its 'FAIL' on the strategy's 'FINAL RANK' due to neutral performance on momentum and net payout yield.
• Consider JNJ if seeking exposure to a large-cap, lower-volatility stock within the Biotechnology & Drugs industry, but be aware that it may not fully satisfy investment criteria for strategies heavily prioritizing strong current momentum and high net payout yields.
• Further due diligence into JNJ's recent momentum trajectory and its components of net payout yield (dividends and share buybacks) is advisable for investors specifically seeking alignment with all tenets of the Pim van Vliet conservative factor model.